SHH:688278

Xiamen Amoytop Biotech Co., Ltd. · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:32 UTC

Last close

n/aCNY

Market data

17.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
35.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
27.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
12.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.05Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

1,318

2016-12-31 to 2025-12-31100 at the start1,318

Sales: 100.00 on 2016-12-31 to 1318.10 on 2025-12-31, up 1218%.

Profit

3,518

2016-12-31 to 2025-12-31100 at the start3,518

Profit: 100.00 on 2016-12-31 to 3517.89 on 2025-12-31, up 3418%.

Shares in issue

125

2016-12-31 to 2025-12-31100 at the start125

Shares in issue: 100.00 on 2016-12-31 to 124.94 on 2025-12-31, up 25%.

Sales is at 1318, Profit is at 3518, Shares in issue is at 125, against 100 in 2016.

Sales is at 1318, Profit is at 3518, Shares in issue is at 125, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 1001,318
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 1003,518
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100125
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY